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The Bladder Cancer-Associated Protein gene (BLCAP; previously BC10) is a tumour suppressor that limits
cell proliferation and stimulates apoptosis. BLCAP protein or message are downregulated or absent in a var-
iety of human cancers. In mouse and human, the first intron of Blcap/BLCAP contains the distinct Neuronatin
(Nnat/NNAT) gene. Nnat is an imprinted gene that is exclusively expressed from the paternally inherited allele.
Previous studies found no evidence for imprinting of Blcap in mouse or human. Here we show that Blcap is
imprinted in mouse and human brain, but not in other mouse tissues. Moreover, Blcap produces multiple dis-
tinct transcripts that exhibit reciprocal allele-specific expression in both mouse and human. We propose that
the tissue-specific imprinting of Blcap is due to the particularly high transcriptional activity of Nnat in brain,
as has been suggested previously for the similarly organized and imprinted murine Commd1/U2af1-rs1 locus.
For Commd1/U2af1-rs1, we show that it too produces distinct transcript variants with reciprocal allele-
specific expression. The imprinted expression of BLCAP and its interplay with NNAT at the transcriptional
level may be relevant to human carcinogenesis.
INTRODUCTION
The Bladder Cancer-Associated Protein gene (BLCAP; pre-
viously BC10) was first identified in a differential gene
expression study where it was found to be specifically silenced
in invasive human bladder transitional cell carcinoma (1).
Loss of BLCAP expression has since also been observed
in renal-cell carcinoma (2) and cervical cancer (3). Over-
expression of BLCAP in HeLa and human tongue carcinoma
cells stimulates apoptosis (3,4). Relative to other tissues, the
Novartis gene expression atlas (SymAtlas) shows BLCAP
mRNA levels to be high in brain, the pituitary and the
immune system (5) (Affymetrix probe set 201032_at).
BLCAP is translated in vitro into a 9.8 kDa protein of 87
amino acids whose function is unknown but which putatively
includes two trans-membrane domains, cytoplasmic domains
at the N and C terminals, a phosphorylation site and may bind
DNA (6) (UniProt/SwissProt: P62952). At the amino acid
level, BLCAP is identical in human, mouse (P62951), orangutan
(Q5R692), rat (P62950), cat (P62953) and cattle (P62954).
Human BLCAP is located on Chr 20q11.2 and is annotated in
RefSeq (NM_006698) as having two exons, with the open
reading frame confined to the last exon. An exceptional
feature of the locus is the existence of a distinct gene,Neuronatin
(NNAT), within the intron of BLCAP. Distinct CpG islands
(CGI) overlap the transcription start sites (TSSs) of both
NNAT and BLCAP, with an additional CGI in the body of
NNAT. NNAT is imprinted and paternally expressed in fetal
brain (7). The same study found 50% of CpGs in a region
encompassing the NNAT CGIs to be methylated in brain and
other tissues, suggestive of differential, maternal allele-specific
methylation. However, no evidence was found for imprinted
expression of BLCAP in fetal brain or other tissues, and the
BLCAP CGI was unmethylated in all investigated tissues (7).
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The orthologous murine Blcap/Nnat locus on Chr 2 largely
recapitulates the genomic organization and expression profile
of human BLCAP/NNAT. The intron harbours Nnat whose
imprinting and paternal-specific expression was first observed
in mouse embryo and newborn brain (8). Blcap mRNA levels
are relatively high in brain and the pituitary, but not the
immune system (SymAtlas probe set gnf1m03525_a_at). In
addition, Blcap expression is high in adipose tissue, oocytes
and zygotes, for which SymAtlas contains no human data.
The promoters of Nnat and Blcap are associated with CGIs
that are smaller than in human. In embryos, the Nnat CGI
and gene body are methylated only on the maternal allele
(9). The Blcap CGI is unmethylated, and expression assays
in androgenetic, parthenogenetic and uniparentally disomic
embryos suggested that Blcap is not imprinted (10).
Here, we show that murine and human Blcap generate mul-
tiple transcripts that are imprinted in the brain where expression
occurs preferentially from either the maternal or the paternal
allele in a transcript-specific manner. For the mouse, we quan-
tify the relative contributions of representative transcripts to
the mRNA pool and demonstrate that the regulation of the
locus depends on maternal germline methylation. We argue
that past studies found no evidence of Blcap imprinting due to
the tissue-specific nature of Blcap imprinting (7,10). We
compare the locus with other imprinted domains where the
gene carrying the primary imprint mark is located in the intron
of a gene that also exhibits parent-of-origin-specific expression
(11,12). Based on similarities with these other loci, we propose
that the high level ofNnat transcription in brain relative to other
tissues contributes to the brain-specific imprinted expression
pattern of Blcap. Our findings shed new light on the epigenetic
regulation of a tumour suppressor gene and have implications
for its deregulation during carcinogenesis.
RESULTS
Multiple Blcap transcripts are generated from distinct
promoters in human and mouse
Several mouse (e.g. CJ174807) and human expressed
sequence tags (ESTs; e.g. DA770824, DA366527,
DA277117) suggested that additional Blcap TSSs exist in
both species. In human, ESTs also indicated an alternatively
spliced third internal BLCAP exon overlapping the NNAT
coding sequence (e.g. DA377434). We have identified at
least four distinct human and two distinct mouse Blcap tran-
scripts (Fig. 1). They fall into two categories, depending on
whether their TSSs are downstream or upstream of Nnat.
We refer to Blcap transcripts with TSSs downstream of Nnat
collectively as Blcap_v1 and denote specific transcripts with
a one letter suffix. Analogously, Blcap_v2 stands for isoforms
with TSSs upstream of Nnat.
Microarray measurements suggest preferential maternal
expression of murine Blcap
We measured gene expression in whole head samples of
newborn mice with maternal and paternal uniparental dupli-
cation (UpDp) of distal Chr 2 (13), which includes the
Blcap locus. Thus, both homologous copies of the Blcap
locus are of either the maternal or the paternal epigenotype.
Two microarrays containing probe sets specific to Blcap
and Nnat (Fig. 1B) were hybridized with a MatDp(dist2)
sample and a PatDp(dist2) sample, respectively. The Blcap
probe set detected 2.4-fold more Blcap expression in
MatDp(dist2) than in PatDp(dist2) material. The Nnat probe
set, as expected, essentially failed to detect Nnat message
in the MatDp(dist2) sample, while registering high Nnat
levels in PatDp(dist2) newborn head (MatDp(dist2)/
PatDp(dist2) ¼ 0.006).
SNP-based allele-specific direct sequencing and
quantitative real-time PCR confirm preferential maternal
expression of Blcap_v1a in mouse brain
AT/A SNP between the C57BL/6J (B6) andMusmus castaneus
(cast) mouse strains was identified in the last Blcap exon
(Fig. 1B). It was used to determine the allelic origin of
Blcap_v1a expression in newborn and adult brain samples of
B6  cast (BC) and cast  B6 (CB) inter-subspecific
hybrid offspring. Blcap_v1a was specifically amplified from
cDNA and directly sequenced. The maternal allele always
dominated the sequencing traces, consistent with preferential
maternal expression of Blcap_v1a (Fig. 2A). For further con-
firmation and to more accurately quantify the contribution of
the parental alleles, we measured Blcap_v1a expression in
MatDp(dist2) and PatDp(dist2) newborn brain samples rela-
tive to a matched non-UpDp control sample by TaqMan quan-
titative real-time PCR (qRT–PCR). We observed 2.2-fold
more Blcap_v1a expression in MatDp(dist2) than in the
control, while PatDp(dist2) brain retained 25% of the
expression level in the control (Fig. 3A). This corresponds
to 8.8-fold more Blcap_v1a transcript in MatDp(dist2)
than in PatDp(dist2) brain, a larger fold-change than observed
via microarray in whole head samples.
Preferential maternal Blcap_v1a expression is present
in embryo, but not in placenta or adult murine
tissues other than brain
A second, G/C SNP between B6 and cast (Fig. 1B) was used
for allele-specific sequencing assays of cDNA derived from
whole embryo at 9.5 days post coitum (dpc), 13.5 dpc placenta
and testis, heart, lung, liver and skeletal muscle tissue of adult
mice. Preferential maternal Blcap_v1a expression was only
observed in embryo (Fig. 2B and Supplementary Material,
Fig. S1), likely due to the brain component of this RNA
sample. Biallelic expression of Blcap_v1a in tissues other
than brain likely contributed to the reduced fold-change
observed via microarray in whole head samples in comparison
to the brain samples assayed by qRT–PCR.
Blcap_v2a originating upstream of Nnat is, like Nnat,
only expressed from the paternal allele
EST evidence for an alternative Blcap TSS upstream of the
Nnat promoter prompted us to determine whether this tran-
script isoform was imprinted (Blcap_v2a in Fig. 1B). We
amplified a product with intron boundaries identical to EST
CJ174807 including almost the entire length of the last
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Blcap exon. Sequencing showed that in newborn brain and
whole embryo, Blcap_v2a was exclusively expressed from
the paternal allele (Fig. 2C). This was confirmed by TaqMan
qRT–PCR: amplification failed in MatDp(dist2) newborn
brain due to a lack of Blcap_v2a transcripts, while an approxi-
mately 2-fold increase of Blcap_v2a was observed in PatDp(-
dist2) newborn brain relative to the non-UpDp control
(Fig. 3A).
Since the microarray probe set for Blcap is located in the
last exon that is shared by Blcap_v1a and Blcap_v2a, the
microarray measurements likely reflect the cumulative levels
of both isoforms. Nevertheless, the microarray detected a
2.4-fold change in MatDp(dist2) relative to PatDp(dist2),
suggesting that the paternally expressed Blcap_v2a is much
less abundant than the predominantly maternally expressed
Blcap_v1a. Based on our previous qRT–PCR measurements
in newborn brain, Blcap_v1a is 100-fold more abundant
than Blcap_v2a (Fig. 3B). Hence, Blcap_v2a is unlikely to
have significantly contributed to the microarray measurements
so that the small MatDp(dist2)/PatDp(dist2) ratio in relation to
the qRT–PCR results is most likely due to the brain-specific
imprinting of Blcap.
Transcript analysis by northern hybridization confirms
findings for Blcap_v1a and Blcap_v2a
Two northern blots with newborn brain RNA of MatDp(dist2),
PatDp(dist2) and non-UpDp mice were hybridized with a
probe to the last Blcap exon and a probe to the first exon of
Blcap_v2a. The former generated a single band in all three
lanes (Fig. 4), which corresponds to the known size of
Blcap_v1a (2079 bp), the more abundant of the two Blcap
transcripts. The lack of additional distinct bands is evidence
for the absence of additional major Blcap transcripts.
However, the last Blcap exon contributes .87% to the
length of the two known transcripts so that additional tran-
scripts with small alternative first exons may have been sub-
sumed in the one band. The band was most intense in the
MatDp(dist2) and least intense in the PatDp(dist2) lane,
even though the RNA load of the PatDp(dist2) lane was
higher (Fig. 4). This indicates that in newborn brain, tran-
scripts sharing the last Blcap exon cumulatively originate
most often from the maternal allele, consistent with the micro-
array measurements in whole newborn head.
The probe specific for Blcap_v2a generated an obvious
band in only the PatDp(dist2) lane at a position consistent
Figure 1. Genomic organization and features of the human BLCAP (A) and murine Blcap (B) loci. Each panel shows a base pair scale, the likely exon–intron
structure of transcripts and the positions of CpG islands (CGIs), single nucleotide polymorphisms (SNPs) and PCR primers referred to in the text. Base pair
coordinates are with respect to the human Mar 2006 v36.1 and the mouse Feb 2006 v36.0 NCBI genome builds. (A) and (B) are drawn to the same scale,
each displaying a genomic region of 13 kb. Transcript structures were inferred from ESTs and the results of the PCR, sequencing and northern blot experiments
described in the text. Transcripts are shown with filled boxes delineating exons and thin lines with chevrons denoting introns and direction of transcription.
(B) also displays the locations of mouse expression microarray (Affymetrix 430v2), TaqMan quantitative real-time PCR and northern probes. The TaqMan
probes are intron-spanning, as indicated. Microarray probes are displayed as small vertical lines, and a frame indicates the probes belonging to the same
probe set. Primer and probe sequences, and experimental conditions are listed in Supplementary Material, Table S1. The figure was generated with the
UCSC genome browser (40).
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with the slightly larger size of Blcap_v2a (2258 bp) relative to
Blcap_v1a. At the same position, a very faint band could be
seen in the non-UpDp lane, but there was no signal in the
MatDp(dist2) lane, indicating paternal-only expression.
Blcap expression is regulated by maternal
germline methylation
In the mouse, the DNA methyltransferase 3-like (Dnmt3l)
protein is required during oogenesis to establish the maternal-
specific methylation marks that in the offspring, control the
parent-of-origin-specific expression of most imprinted genes
(14,15). In Dnmt3l2/þ offspring of Dnmt3l2/2 dams and
wild-type sires, the imprinting control regions (ICRs) that nor-
mally carry a maternal methylation mark are unmethylated on
both alleles, leading to the misregulation of developmentally
crucial imprinted genes and death by 9.5 dpc (14). Our pre-
vious microarray measurements of gene expression in
Dnmt3l2/þ 8.5 dpc embryos versus wild-type litter mates
showed a decrease of Blcap expression to 70% of wild-type
levels and an increase in Nnat expression by 40% (16).
Measurements of Blcap_v1a and Blcap_v2a by qRT–PCR
showed a reduction of Blcap_v1a in Dnmt3l2/þ embryos to
50% of wild-type levels, whereas Blcap_v2a levels
increased by 40% (Fig. 3C).
In embryo, the Nnat promoter (including a BssHII restric-
tion site 50 bp upstream of the TSS) and gene body were
previously shown to be methylated on only the maternal
allele (9). In human, differential methylation of NNAT has
been observed even farther upstream, to within the last exon
of BLCAP (7). The above changes in Blcap expression
levels in Dnmt3l2/þ embryos are consistent with the notion
that this methylation mark is established during oogenesis
and that in the offspring, it acts as the ICR of the Blcap
locus. To investigate this further, we performed a bisulfite
mutagenesis methylation assay of the Blcap_v2a and Nnat
Figure 2. Allele-specific sequencing results for murine Blcap. (A) The two
top-most rows of sequencing traces labelled gDNA (genomic DNA) show
the B6 (T) and cast (A) genotypes at the site of the T/A SNP between the
two strains (Fig. 1B). The other rows contain the traces obtained from amplify-
ing and sequencing Blcap_v1a using adult (ad) and newborn (nb) brain (Br)
cDNA samples of B6  cast (BC) and cast  B6 (CB) inter-subspecific
hybrids (denoted in dam  sire order). In both adult and newborn brain and
for both directions of the cross, the dominant peak in the trace at the site of
the SNP corresponds to the maternal allele, indicating Blcap_v1a expression
from preferentially the maternal allele. (B) A G/C SNP between B6 and
cast (top gDNA traces and Fig. 1B) was used to determine the allelic origin
of Blcap_v1a expression in 9.5 dpc embryo (Em). The maternal allele domi-
nated the sequence traces for the BC and CB hybrid embryo samples, indi-
cating preferential maternal expression. (C) The same T/A SNP as in (A) was
used to test for allele-specific expression of Blcap_v2a (Fig. 1B). In BC and
CB newborn brain and whole embryo, Blcap_v2a was expressed from exclu-
sively the paternal allele, in contrast to Blcap_v1a. (D) Allele-specific sequen-
cing of transcripts in the first intron of Blcap_v1a using a T/C SNP between
the B6 and cast strains (top gDNA traces and Fig. 1B). Transcripts amplified
from BC and CB newborn (nb) brain (Br) were predominantly expressed
from the paternal allele.
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promoter region (Supplementary Material, Fig. S2). Overall,
we observed a loss of methylation in Dnmt3l2/þ relative to
wild-type samples across the entire region, suggesting that
its methylation significantly depends on the activity of
Dnmt3l during oogenesis.
Human orthologues of Blcap_v1a and Blcap_v2a are
imprinted in fetal brain
The genomic organization of the human BLCAP locus is
similar to murine Blcap, including alternative BLCAP iso-
forms (Fig. 1A). BLCAP_V1a, b and c are orthologous to
Blcap_v1a in the sense that their TSSs are downstream of
NNAT. Analogously, BLCAP_V2a upstream of NNAT is ortho-
logous to Blcap_v2a. To determine whether this similarity
extends to the imprinting status of these BLCAP isoforms,
we performed allele-specific sequencing assays in brain
samples of human fetuses that were heterozygous for a TGn
repeat copy number polymorphism (rs_11474161) in the last
BLCAP exon where n ¼ 7 or n ¼ 8, i.e., n differed between
the parental alleles by one.
In fetus no. 1, BLCAP_V1a, b and c were predominantly
expressed from the n ¼ 7 allele, while BLCAP_V2a transcripts
originated from the n ¼ 8 allele, indicating reciprocal allele-
specific expression (Fig. 5). Primers designed to the last
BLCAP exon, thought to be shared by all isoforms, amplified
only the n ¼ 7 allele, suggesting that the BLCAP_V1 isoforms
transcribed from the n ¼ 7 allele are overall more abundant
than isoforms like BLCAP_V2a that are expressed from the
n ¼ 8 allele. This recapitulates our observations on the relative
expression levels of Blcap_v1a and Blcap_v2a in the mouse.
For fetus no. 1, no parental sample was available, precluding
parent-of-origin determination. For a second fetus (no. 2),
maternal genomic DNA (gDNA) was available and the
maternal genotype was n ¼ 7 (Fig. 5). Predominantly
the maternal n ¼ 7 allele of BLCAP_V1a, b and c was present
in brain cDNA of fetus no. 2, as opposed to BLCAP_V2a
which originated exclusively from the paternal n ¼ 8 allele
(Fig. 5). These data indicate that the parent-of-origin-specific
expression profile of murine Blcap is conserved in human,
Figure 3. TaqMan quantitative real-time PCR (qRT–PCR) measurements of
Blcap_v1a and Blcap_v2a. Error bars indicate the 95% confidence interval.
(A) Blcap_v1a and Blcap_v2a levels in MatDp(dist2) and PatDp(dist2)
newborn (nb) brain relative to a matched non-UpDp control (T11H).
Blcap_v1a was 2.2 times more abundant in MatDp(dist2) than in control
nb brain, and achieved only 25% of the control expression level in
PatDp(dist2) nb brain, which corresponds to a MatDp(dist2)/PatDp(dist2)
expression ratio of 8.8. This reflects the preferential maternal expression
of Blcap_v1a. Blcap_v2a was not present in MatDp(dist2) nb brain (no ampli-
fication), and 2-fold more abundant in PatDp(dist2) than in non-UpDp nb
brain, consistent with paternal-only expression. (B) Left bar: amount of
Blcap_v2a in PatDp(dist2) nb brain relative to Blcap_v1a in MatDp(dist2)
nb brain. Right bar: amount of Blcap_v2a in non-UpDp nb brain relative to
Blcap_v1a in the same sample. In both cases, Blcap_v2a reached only 1%
of the Blcap_v1a transcript level, i.e. in nb brain, Blcap_v1a is 100-fold
more abundant than Blcap_v2a. (C) Quantification of Blcap_v1a and
Blcap_v2a levels in 8.5 dpc Dnmt3l2/þ embryos relative to wild-type (WT)
litter-mates. Expression of Blcap_v1a was reduced to 50% of WT level in
Dnmt3l2/þ embryos, while Blcap_v2a increased in abundance by 40%.
This is consistent with the notion that the maternal allele-specific methylation
of the Nnat promoter CGI is established during oogenesis and that methylation
of this CGI positively regulates Blcap_v1a expression, while it inhibits
Blcap_v2a expression.
Figure 4. Detection of Blcap_v1a and Blcap_v2a in MatDp(dist2), PatDp(-
dist2) and non-UpDp (T11H) newborn brain RNA by northern hybridization.
The signal obtained with an Actb probe is shown as a loading control (bottom).
Left: Hybridization signal produced by the probe designed to the last Blcap
exon (N1 in Fig. 1B). A single band was observed in all three lanes where
the relative band intensity was highest in the MatDp(dist2) lane and lowest
in the PatDp(dist2) lane. Band position and relative intensities were consistent
with the known size of the major Blcap transcript Blcap_v1a (2079 bp) and
overall preferential expression of Blcap from the maternal allele in newborn
brain. Right: Results obtained with a probe specific to the first exon of
Blcap_v2a (N2 in Fig. 1B). No band was present in the MatDp(dist2) lane.
A single band was visible in the PatDp(dist2) lane. At the corresponding pos-
ition in the non-UpDp lane, a very faint band was present. This indicates
paternal-only expression of Blcap_v2a. The band was slightly shifted
upward relative to the band obtained with the N1 probe, as is expected of
the slightly larger Blcap_v2a (2258 bp). The exposure times necessary to visu-
alize the results for Blcap_v2a were considerably longer than for the N1 probe,
which is consistent with the low abundance of Blcap_v2a relative to
Blcap_v1a as determined by qRT–PCR.
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including the relatively minor contribution of paternal tran-
scripts like BLCAP_V2a to the overall BLCAP transcript pool.
Paternal allele-specific transcripts extending into
the first intron of Blcap_v1a
The first intron of Blcap_v1a prior to Nnat contains three
AATAAA polyadenylation (polyA) site motifs in the sense
orientation relative to Blcap. Two of them are only 25 bp
apart, are located within a 60 bp region that is evolutionarily
conserved among mammals, and coincide with the ends of
multiple ESTs and an mRNA that likely correspond to Blcap
transcripts (BY664891, CJ320720, AV349270, BB178170,
AK038884). However, they may also correspond to anti-sense
transcripts generated by Nnat. All these transcripts were
recovered from brain tissues or Rathke’s pouch, an embryonic
precursor of parts of the pituitary.
Allele-specific sequencing assays were performed using a
T/C SNP between B6 and cast near the start of the
Blcap_v1a intron (Fig. 1B). Multiple, differentially spliced
transcripts were amplified from newborn brain. Sequencing
of amplicons that covered the SNP position and whose par-
ental origin could thus be determined, revealed that they origi-
nated from the paternal allele (Fig. 2D).
The Commd1/U2af1-rs1 locus generates paternal
allele-specific transcripts similar to Blcap_v2a
The murine Commd1 (¼Murr1)/U2af1-rs1 locus on proximal
Chr 11 has been noted previously as being similar in organiz-
ation to Blcap/Nnat (11). In previous microarray experiments,
we compared MatDp(prox11) with PatDp(prox11) tissues,
including brain (17). For Commd1/U2af1-rs1, these microarray
measurements reflected the known preferential maternal
expression of Commd1 and the paternal-only expression of
U2af1-rs1 in brain (11,18). However, as with Blcap, we found
EST evidence (e.g. BG074660, BE137092, BU582903) for
alternativeCommd1 transcripts (Commd1_v2a, b, c) originating
from within or near the 50-end of the intronic U2af1-rs1 gene
(Supplementary Material, Fig. S3A). Using a G/A SNP
between the B6 and cast strains in the first exon of
Commd1_v2b, we determined that this isoform is exclusively
Figure 5. Human allele-specific sequencing results. For each fetus, the top row contains a trace generated from genomic DNA (gDNA). For fetus no. 1 (left), this
trace demonstrates heterozygosity for a TGn repeat copy number polymorphism in the last BLCAP exon (n ¼ 7 for one allele, and n ¼ 8 for the other; asterisks
highlight the additional TG dinucleotide). For fetus no. 2 (middle), the maternal gDNA trace shows the maternal genotype to be n ¼ 7. The second and subsequent
rows display traces obtained with fetal brain cDNA. In fetus no. 1, only the n ¼ 7 allele is evident after sequencing of PCR products generated with primers designed
to the last BLCAP exon, thought to be common to all BLCAP isoforms. Similar results were observed for amplicons specific to isoforms BLCAP_V1a and c,
BLCAP_V1b and BLCAP_V1c. This was also the case for fetus no. 2. In contrast, the n ¼ 8 allele was seen upon sequencing BLCAP_V2a products in both
fetuses nos 1 and 2 (framed traces; asterisks highlight the additional TG). These data indicate that BLCAP_V2a is predominantly expressed from the paternal
allele, while the other isoforms are preferentially expressed from the maternal allele. For comparison, an n ¼ 7 homozygous fetus (no. 3) is shown on the right.
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paternally expressed (Supplementary Material, Fig. S3B). The
Commd1 microarray probe sets map to the second and third
Commd1 exons that are common to all isoforms (Supplemen-
taryMaterial, Fig. S3A). The fact that they detected preferential
maternal expression suggests that paternal Commd1 transcripts
like Commd1_v2a are much less abundant than the maternally
expressed Commd1_v1a that was assayed in reference (11),
similar to the relative abundances of Blcap_v1a and Blcap_v2a.
DISCUSSION
Tissue- and promoter-specific imprinting of Blcap/Blcap
The BLCAP/Blcap locus generates transcripts from distinct
promoters downstream (BLCAP_V1/Blcap_v1) and upstream
(BLCAP_V2/Blcap_v2) of NNAT/Nnat (Fig. 1). We found
Blcap_v1a to be preferentially expressed from maternally
inherited alleles in brain but not other murine tissues, indicat-
ing brain-specific imprinting (Fig. 2A and Supplementary
Material, Fig. S1). Similarly, BLCAP_V1 transcripts are pre-
ferentially maternally expressed in human fetal brain
(Fig. 5). In contrast, the BLCAP_V2a/Blcap_v2a isoforms
are predominantly paternally expressed in brain (Figs 2C
and 5). In mouse brain, Blcap_v1a is much more abundant
than Blcap_v2a (Fig. 3B), explaining the overall dominance
of Blcap transcripts from maternal alleles (microarray data
and Fig. 4), which is also evident in human (Fig. 5). The tran-
scriptional profile of BLCAP/Blcap is thus a complex combi-
nation of tissue-specific expression, promoters of different
efficiencies and tissue- and promoter-specific imprinting.
This complexity is reminiscent of theGRB10/Grb10 locus. In
mouse, the ‘major’ Grb10 promoter is active in a range of
tissues but only on maternally inherited alleles (19), while dis-
tinct brain-specific promoters are utilized on only paternal
alleles (20–23). In human, the ‘major’ GRB10 promoter is
active on both parental alleles (20,24,25). BLCAP/Blcap thus
shares the promoter-specific expression of either predominantly
the maternal or the paternal alleles (Figs 2A and C), but in con-
trast to GRB10/Grb10, this ‘reciprocal’ imprinting pattern
occurs in the same tissue and is conserved in human (Fig. 5).
Previously, Blcap expression has been detected by qualitat-
ive methods in both parthenogenote and androgenote as well
as in MatDp(dist2) and PatDp(dist2) mouse embryos (10).
This is consistent with the contribution of non-brain tissues
in which we found Blcap_v1a to be expressed biallelically
(Supplementary Material, Fig. S1) and the incomplete silen-
cing of the paternal allele of Blcap_v1a even in brain
(Figs 2A and 3A). Similarly in human, a qualitative expression
assay yielded biallelic results for BLCAP in various fetal
tissues including brain (7). The brain-specific result is again
probably due to the incomplete suppression of BLCAP_V1
transcription from the paternal allele (Fig. 5).
Transcriptional interference hypothesis
The Blcap/Nnat locus is similar in many respects to the
Commd1/U2af1-rs1 locus (11,18). Commd1_v1a is preferen-
tially maternally expressed, particularly in adult brain where
the paternally expressed U2af1-rs1 is abundant relative to
earlier developmental stages and other tissues (11). In situ
hybridizations showed Commd1 and U2af1-rs1 to be
co-expressed widely throughout the brain and in the same
cell types (11). In addition, paternally expressed anti-sense
transcripts overlap the Commd1_v1a promoter region, are
most abundant in brain and likely correspond to U2af1-rs1
transcripts (11). Transcription of U2af1-rs1 through the
Commd1_v1a promoter was postulated to interfere with
Commd1_v1a expression in cis where the degree of inter-
ference directly relates to U2af1-rs1 expression levels (11).
This transcriptional interference mechanism would explain
the imprinted expression profile of Commd1_v1a.
Here, we have shown that specifically in brain, Blcap_v1a,
like Commd1_v1a, is preferentially expressed from the
maternal allele. Nnat, like U2af1-rs1, is highly expressed in
brain compared to other tissues. Nnat expression is particu-
larly low in the murine tissues in which we found
Blcap_v1a to be biallelically expressed (Fig. 2B). A Neuro-
Blast (26) search, based on the in situ hybridization data for
thousands of genes that compose the Allen Brain Atlas (27),
found Blcap to have the most similar expression pattern in
brain relative to Nnat (Supplementary Material, Table S2).
This suggests that in brain, Nnat and Blcap are co-expressed
in the same cell types. Our data on paternal allele-specific
transcripts in the first intron of Blcap_v1a may reflect Nnat
transcripts extending through the Blcap_v1a promoter region
(Fig. 2D). Thus, the transcriptional interference mechanism
proposed by Wang et al. (11) for Commd1/U2af1-rs1 may
also be acting at the Blcap/Nnat locus.
Alternative polyadenylation hypothesis
For the H13/Mcts2 imprinted locus, we recently demonstrated
parent-of-origin-specific H13 polyA site selection (12). An
H13 intron contains the paternally expressed gene Mcts2.
Alternative H13 polyA sites upstream of Mcts2 are preferen-
tially utilized on the paternal allele. On the maternal allele,
H13 transcription proceeds through the inactive Mcts2 to
downstream polyA sites. The ICR of the locus is a CGI over-
lapping the Mcts2 promoter that carries a maternal germ-line
methylation mark. The organization of the H13/Mcts2 locus
thus is similar to Blcap/Nnat. The paternal allele-specific tran-
scripts overlapping the first exon and extending into the intron
of Blcap_v1a (Fig. 2D), instead of being generated by Nnat,
may reflect the use of an alternative Blcap polyA site on
specifically paternal alleles and preferentially in brain. This
assumes that high transcriptional activity of Nnat can reduce
the utilization of the canonical Blcap polyA site in favour
of the alternative site. Like transcriptional interference,
alternative polyA could explain the observed brain-specific
preferential maternal expression of Blcap_v1a.
Possible implications of BLCAP/NNAT imprinting
for carcinogenesis
Expression studies in various cancers have consistently found
BLCAP to be absent or down-regulated relative to normal or
less severe controls (Supplementary Material, Table S3). Redu-
cing BLCAP expression by RNAi in osteosarcoma cells has
been reported to increase cell growth and colony formation,
alters the cell cycle and promotes cell proliferation (28).
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In contrast, over-expression of BLCAP in HeLa and human
tongue cancer cells has been shown to stimulate apoptosis (3,4).
Similar studies of NNAT include observations of down- as
well as up-regulation in different cancers (Supplementary
Material, Table S3). Several of these investigations assessed
the DNA methylation state of the NNAT promoter and/or the
effect of DNA de-methylation agents on the expression of
NNAT, but none of the reports about elevated NNAT
expression in cancer included information on its methylation
state. De-methylation and reactivation of maternal NNAT
may have occurred in these cases. Global as well as locus-
specific hypomethylation, often in introns, has previously
been observed in cancer (29,30).
In the context of the transcriptional interference model, this
may be relevant to carcinogenesis in tissues like brain where
NNAT is highly expressed. Reactivation of maternal NNAT
would lead to an overall down-regulation of BLCAP, akin to
our results for Blcap in Dnmt3l2/þ mouse embryos
(Fig. 3C). So, with respect to BLCAP expression levels, hypo-
methylation of NNAT would have an effect similar to hyper-
methylation and silencing of the BLCAP promoter.
NNAT and BLCAP have not been studied in concert in cancer
biology. Some studies employed large-scale methods that
implicitly generated limited data for both genes (31,32). Care
needs to be taken when choosing polymorphisms for allele-
specific profiling: BLCAP message is the target of RNA
editing, particularly in brain, generating what appear to be
A/G SNPs (33,34). We believe that a simultaneous allele-
specific profiling of NNAT and BLCAP expression and chroma-
tin modifications in tumours and cell lines would be insightful.
MATERIALS AND METHODS
Mouse samples
Tissues of B6, cast and inter-subspecies hybrids (BC and
CB) were dissected, snap-frozen and stored at 2808C.
The MatDp(dist2), PatDp(dist2) and non-UpDp control
newborn mice were generated as described in reference (13).
Briefly, these mice are the offspring of heterozygotes for the
T(2:9)11H reciprocal translocation that have inherited the
distal part of both homologous copies of Chr 2 from either
the mother, MatDp(dist2), or the father, PatDp(dist2), due to
a non-disjunction event. The non-UpDp controls were carriers
of the T(2:9)11H translocation with an otherwise normal, that
is, biparental and balanced genome. The generation of the
8.5 dpc Dnmt3l2/þ embryos and normal litter mates is
described in reference (14). RNA and DNA were extracted
with the Qiagen RNeasy mini (Cat. No. 74104) and DNeasy
tissue kits (Cat. No. 69504) following manufacturer protocols.
cDNA was made with the Invitrogen Superscript First-Strand
Synthesis System (Cat. No. 12371-019). Between 1 and 5 mg
of total RNA, quantified with an Agilent 2100 BioAnalyzer,
were used in a standard 50 ml oligo dT-primed reaction fol-
lowing the manufacturer protocol.
Human samples
The brain samples of fetuses 1 and 3 were obtained from the
MRC-Wellcome Human Developmental Biology Resource.
RNA and DNA were extracted with the Qiagen RNeasy
mini (Cat. No. 74104) and DNeasy tissue kits (Cat. No.
69504) following manufacturer protocols. cDNA was syn-
thesized using the Invitrogen Superscript First-Strand Syn-
thesis System (Cat. No. 12371-019). For fetus F46, brain
cDNA and maternal genomic DNA samples were collected
under the guidelines of the Hammersmith and Queen
Charlotte’s and Chelsea Hospitals Trust Research Ethics Com-
mittee (Registration No. 2005/6028). Informed consent was
collected from all subjects.
Expression microarrays
Two Affymetrix MOE 430 v2 expression microarrays were
hybridized with probes produced from total RNA samples of
the whole heads of a MatDp(dist2) and a PatDp(dist2)
newborn mouse, respectively. Probe generation, array hybrid-
ization and analysis are described in references (16) and (17).
The data can be viewed using WAMIDEX (https://atlas.gen-
etics.kcl.ac.uk), the web interface to our collection of
imprinting-related microarray data (16). The raw array data
are available from GEO (GSE11789).
PCR
All reactions were performed using Abgene Reddymix (Cat.
No. AB-0575/LD/A). Unless noted otherwise, total reaction
volume was 10 ml, including 1 ml cDNA template and 0.5 ml
mix of 20 mM forward and reverse primer. Primer sequences
and cycling conditions are listed in Supplementary Material,
Table S1. Primers were designed using Primer3Plus (35).
For fetus F46, two rounds of PCR with nested primers were
necessary to obtain enough product from brain cDNA for
sequencing. Two microlitre of the first round PCR reaction
were used as template in the second round.
DNA sequencing
2.5 ml of PCR reaction was treated with 1 ml USB Exosap-IT
(Cat. No. 78200) in a 15 ml reaction to inactivate primers and
unincorporated nucleotides. Depending on the concentration
of the PCR product as estimated by gel electrophoresis using
1.2% agarose, 2.5 or 5 ml of the Exosap reaction were used
as template in a 10 ml sequencing reaction together with
0.5–1.0 ml BigDye and 2 ml 5 sequencing buffer from the
ABI BigDye v3.1 kit (Cat. No. 4337455) and 0.4 ml 20 mM
primer. Primer sequences and cycling conditions are listed in
Supplementary Material, Table S1. The products were precipi-
tated with 300 mM sodium acetate in ethanol, collected by
centrifugation, washed with 70% ethanol, resuspended and
denatured in formamide and sequenced on an ABI 3730xl
sequencer. Sequence reads were analysed with the Staden
package (http://staden.sourceforge.net/) (36).
qRT–PCR
Custom TaqMan gene expression assays (primer-probe mixes)
for Blcap_v1a and v2a were ordered from ABI (Cat. No.
4331348). One microlitre of cDNA template was diluted in
3.5 ml water and added to 0.5 ml primer-probe mix in 5 ml
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ABI TaqMan Gene ExpressionMaster Mix (Cat. No. 4370048).
The reactions were performed on an ABI 7900ht Lightcycler
and analysed using the DDCt method with Actb as the endogen-
ous control (37). The confidence intervals shown in Figure 3 are
based on four replicate reactions per transcript and template.
Primer and probe sequences and cycling conditions are listed
in Supplementary Material, Table S1.
Northern hybridization
Two blots were generated in parallel from 10 mg per well of
total RNA extracted from single MatDp(dist2), PatDp(dist2)
or non-UpDp control newborn brains. Size estimates are
based on a DNA ladder run in parallel. PCR primers and con-
ditions for the generation of the templates for the 200 bp
probes N1 and N2 shown in Figure 1B are given in Sup-
plementary Material, Table S1. Twenty microlitre of template
PCR product was purified by gel electrophoresis in 1.2% low
melting point agarose and gel-extracted with the Qiagen
QiaEx II kit (Cat. No. 20021). Five microlitre (25 ng) of
purified template was used to make adCT 32P-labelled probe
with the NEBlot kit (Cat. No. N1500S) in a standard 50 ml
reaction, which was purified with a Roche mini Quick Spin
DNA Column (Cat. No. 11814419001). The probe in 10 ml
Sigma PerfectHyb solution (Cat. No. H7033-125ML) was
incubated with the respective blot (pre-hybridized with
10 ml PerfectHyb for 2hrs) at 658C overnight. Blots were
washed at 658C for 20 min in 2% SSC, 0.5% SDS and for
40 min in 0.5% SSC, 0.5% SDS. The blot probed with N1
(last Blcap exon) was exposed to phosphor screen for 15 h.
The exposure time for the N2 blot (Blcap_v2a exon 1) was
84 h. The phosphor screen was scanned with an Amersham
Typhoon 9200 Variable Mode Imager at 50 mm resolution.
Bisulfite mutagenesis DNA methylation assay
Genomic DNA extracted from 7.75 dpc Dnmt3l2/þ and wild-
type visceral yolk sac (VYS) tissue was bisulfite-converted
using the Zymo Research EZ DNA Methylation-Direct Kit
(Cat. No. D5020) according to the manufacturer’s protocol
(500 ng input DNA per reaction). Genomic DNA of
8.5 dpc Dnmt3l2/þ embryos was converted as described
(12). Four microlitre of converted DNA were used for each
PCR with Thermoprime Taq DNA polymerase (Thermo
Scientific Cat. No. AB-0301) according to the manufacturer’s
protocol, adjusted for a 20 ml reaction volume and the addition
of 4 ml 5M Betaine (Sigma Cat. No. B0300). The products
were directly sequenced as well as cloned and sequenced
using the pGEM-T Easy vector (Promega Cat. No. A1360)
and DH5a competent cells (Invitrogen). Primers and cycling
conditions are provided in Supplementary Material,
Table S1. Primers were designed using BiSearch (38).
‘Beads-on-a-string’ diagrams were produced with BiQ
Analyzer (39).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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